首页> 外文期刊>Trends in pharmacological sciences >Tackling TAMs for Cancer Immunotherapy: It’s Nano Time
【24h】

Tackling TAMs for Cancer Immunotherapy: It’s Nano Time

机译:解决癌症免疫疗法的TAMS:这是纳米时间

获取原文
获取原文并翻译 | 示例
           

摘要

The tumor microenvironment (TME) is a highly complex environment that surrounds tumors. Interactions between cancer cells/non-cancerous cells and cells/non-cell components in the TME support tumor initiation, development, and metastasis. Of the cell types in the TME, tumor-associated macrophages (TAMs) have gained attention owing to their crucial roles in supporting tumors and conferring therapy resistance. Recent developments in nanotechnology raise opportunities for the application of nano targeted drug-delivery systems (Nano-TDDS) in cancer therapy. We focus our discussion on current knowledge of TAMs, and describe recent examples of Nano-TDDS-based TAM modulation, highlighting strategies to overcomein vivodelivery barriers associated with the TME and their potential for clinical translation.
机译:肿瘤微环境(TME)是一个高度复杂的肿瘤周围环境。TME中癌细胞/非癌细胞和细胞/非细胞成分之间的相互作用支持肿瘤的发生、发展和转移。在TME中的细胞类型中,肿瘤相关巨噬细胞(TAM)因其在支持肿瘤和赋予治疗耐药性方面的关键作用而受到关注。纳米技术的最新发展为纳米靶向给药系统(nano-TDDS)在癌症治疗中的应用提供了机会。我们将讨论的重点放在目前关于TAM的知识上,并描述了基于纳米TDDS的TAM调制的最新实例,重点介绍了克服与TME相关的活体肝屏障的策略及其临床翻译的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号